1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Italy >
  5. PI Health Sciences Acquires Archimica

M&A Deal Summary

PI Health Sciences Acquires Archimica

On April 28, 2023, PI Health Sciences acquired life science company Archimica from LIVIA Corporate Development

Acquisition Highlights
  • This is PI Health Sciences’ 1st transaction in the Life Science sector.
  • This is PI Health Sciences’ 1st transaction in Italy.

M&A Deal Summary
Date 2023-04-28
Target Archimica
Sector Life Science
Buyer(s) PI Health Sciences
Sellers(s) LIVIA Corporate Development
Deal Type Add-on Acquisition

Target

Archimica

Lodi, Italy
Archimica offers small- to large-scale commercial manufacturing as well as analytical support for the global biopharmaceutical market. The company is specialized in custom synthesis and the manufacture of active pharmaceutical ingredients (“APIs”). Archimica was founded in 1946 and is based in Lodi, Italy.

Search 214,600 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

PI Health Sciences

Mumbai, India
Category Company
Founded 1946
Sector Life Science
DESCRIPTION

PI Health Sciences is a Contract Research, Development and Manufacturing Organization (CRDMO) with R&D and manufacturing locations in Europe (Italy), and India (Hyderabad, Panoli, Jaipur, Ankleshwar) providing end to end solutions from discovery through development and manufacturing for both its big pharma and biotech partners. PI Health Sciences was founded in 1946 and is based in Mumbai, Maharashtra.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
Country: Italy M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

LIVIA Corporate Development

Investor Investor Investor Investor Investor

Category Corporate Investor
Founded 2013
PE ASSETS 782M EUR
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

LIVIA Corporate Development is the direct investment arm of the LIVIA Group, a diversified German holding company. LIVIA Corporate Development looks to acquire non-core divestitures, spin-offs, businesses facing succession issues as well as restructuring situations. The Firm does not have any stated sector preferences, however prefers opportunities in Western Europe. The Group targets businesses and units with €20 million to €2 billion of revenue. LIVIA Corporate Development SE is headquartered in Munich.

DEAL STATS #
Overall 2 of 3
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 3
Country: Italy M&A 1 of 1
Year: 2023 M&A 1 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-07-08 Tingari

Paris, France

Tingari is a provider of professional integration and occupational mobility. Tingari is based in Paris, France.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-05-14 Westpole

Vilvoorde, Belgium

Westpole is an IT Services & Solutions provider that represents the ideal partner for the Digital Transformation of business, thanks to 40+ years of experience in Technology and Innovation management. Westpole is based in Vilvoorde, Belgium.

Sell -
Mergr

Solution for

Product

Company

Legal